On July 8, according to The Block, Nasdaq-listed medical technology company BioSig Technologies (BSGM) announced on Monday that it has reached a financing agreement of up to $1.1 billion with an undisclosed institutional investor to promote the on-chaining of the commodity market. The financing includes $100 million in senior secured convertible bonds and a $1 billion equity line of credit. This financing follows BioSig's completion of a merger with Bahamas-based Streamex Exchange Corporation, marking the company's strategic transformation towards real-world asset tokenization. BioSig CEO and Streamex co-founder Henry McPhie said that the company's mission is to provide liquidity, transparency and accessibility to the $142 trillion commodity market. [Deep Tide TechFlow]

Nasdaq-listed BioSig Raises $1.1 Billion to Promote On-Chain Commodity Markets